Norjavaara E - Search Results

1

Normal pregnancy outcomes in a population-based study including 2,968 pregnant women exposed to budesonide.

Norjavaara E, de Verdier MG. Norjavaara E, et al. J Allergy Clin Immunol. 2003 Apr;111(4):736-42. doi: 10.1067/mai.2003.1340. J Allergy Clin Immunol. 2003. PMID: 12704351

2

Use of inhaled corticosteroids and bone mineral density in a population based study: the Nord-Trøndelag Health Study (the HUNT Study).

Langhammer A, Norjavaara E, de Verdier MG, Johnsen R, Bjermer L. Langhammer A, et al. Among authors: norjavaara e. Pharmacoepidemiol Drug Saf. 2004 Aug;13(8):569-79. doi: 10.1002/pds.941. Pharmacoepidemiol Drug Saf. 2004. PMID: 15317039

3

Is there an association between inhaled corticosteroids and bone density in postmenopausal women?

Elmståhl S, Ekström H, Galvard H, Johnell O, Gerhardsson de Verdier M, Norjavaara E. Elmståhl S, et al. Among authors: norjavaara e. J Allergy Clin Immunol. 2003 Jan;111(1):91-6. doi: 10.1067/mai.2003.4. J Allergy Clin Immunol. 2003. PMID: 12532102 Clinical Trial.

4

Budesonide-treated asthmatic adolescents attain target height: a population-based follow-up study from Sweden.

Larsson L, Gerhardsson de Verdier M, Lindmark B, Norjavaara E. Larsson L, et al. Among authors: norjavaara e. Pharmacoepidemiol Drug Saf. 2002 Dec;11(8):715-20. doi: 10.1002/pds.762. Pharmacoepidemiol Drug Saf. 2002. PMID: 12512249

5

Adult height in women with childhood asthma--a population-based study.

Norjavaara E, Gerhardsson de Verdier M, Lindmark B. Norjavaara E, et al. Pharmacoepidemiol Drug Saf. 2001 Mar-Apr;10(2):121-5. doi: 10.1002/pds.580. Pharmacoepidemiol Drug Saf. 2001. PMID: 11499850

6

Reduced height in swedish men with asthma at the age of conscription for military service.

Norjavaara E, Gerhardsson De Verdier M, Lindmark B. Norjavaara E, et al. J Pediatr. 2000 Jul;137(1):25-9. doi: 10.1067/mpd.2000.107384. J Pediatr. 2000. PMID: 10891817

7

No association between inhaled corticosteroids and whole body DXA in postmenopausal women.

Elmståhl S, Ekström H, Johnell O, Gerhardsson de Verdier M, Norjavaara E. Elmståhl S, et al. Among authors: norjavaara e. Pharmacoepidemiol Drug Saf. 2006 Jul;15(7):527-35. doi: 10.1002/pds.1255. Pharmacoepidemiol Drug Saf. 2006. PMID: 16715539

8

Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study.

Tamborlane WV, Laffel LM, Shehadeh N, Isganaitis E, Van Name M, Ratnayake J, Karlsson C, Norjavaara E. Tamborlane WV, et al. Among authors: norjavaara e. Lancet Diabetes Endocrinol. 2022 May;10(5):341-350. doi: 10.1016/S2213-8587(22)00052-3. Epub 2022 Apr 1. Lancet Diabetes Endocrinol. 2022. PMID: 35378069 Free PMC article. Clinical Trial.

9

Tolerability, pharmacokinetics, and pharmacodynamics of the glucokinase activator AZD1656, after single ascending doses in healthy subjects during euglycemic clamp.

Ericsson H, Röshammar D, Wollbratt M, Heijer M, Persson M, Ueda S, Leonsson-Zachrisson M, Norjavaara E. Ericsson H, et al. Among authors: norjavaara e. Int J Clin Pharmacol Ther. 2012 Nov;50(11):765-77. doi: 10.5414/CP201747. Int J Clin Pharmacol Ther. 2012. PMID: 22943931 Clinical Trial.

10

The glucokinase activator AZD6370 decreases fasting and postprandial glucose in type 2 diabetes mellitus patients with effects influenced by dosing regimen and food.

Ericsson H, Sjöberg F, Heijer M, Dorani H, Johansson P, Wollbratt M, Norjavaara E. Ericsson H, et al. Among authors: norjavaara e. Diabetes Res Clin Pract. 2012 Dec;98(3):436-44. doi: 10.1016/j.diabres.2012.09.025. Epub 2012 Sep 23. Diabetes Res Clin Pract. 2012. PMID: 23010558 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters